Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NiTraSarc Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas - The NiTraSarc Phase II Trial

NCT03590210 is registered in ClinicalTrials.gov with University Medicine Greifswald as lead sponsor.

NCT NCT03590210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03590210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NiTraSarc Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas - The NiTraSarc Phase II Trial
Lead sponsor
University Medicine Greifswald
Phase
Phase 2
Overall status
Completed
Start date
June 8, 2018
Completion date
February 12, 2022
Enrollment
92 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic adult soft tissue sarcoma